Caas Capital Management LP Werewolf Therapeutics, Inc. Transaction History

Caas Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.43 - $5.98 $133,756 - $233,196	-38,996 Reduced 38.38%	62,599 $256,000
Q1 2022 May 13, 2022	SELL	$3.71 - $12.22 $226,324 - $745,468	-61,004 Reduced 37.52%	101,595 $447,000
Q3 2021 Nov 15, 2021	BUY	$13.89 - $20.31 $869,500 - $1.27 Million	62,599 Added 62.6%	162,599 $2.79 Million
Q2 2021 Aug 16, 2021	BUY	$11.6 - $17.44 $1.16 Million - $1.74 Million	100,000 New	100,000 $1.74 Million

31.8M

700

500

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $52.3M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.